How GLP-1 weight-loss drugs work and why theyre so popular Researchers developed the GLP-1 drug, Ozempic, to treat Type 2 diabetes
* Correspondence: Soumendra Rana, [email protected] Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
2022, NEJM) showed 20.9 percent weight loss at 72 weeks, the primary clinical reference OptumRx uses when evaluating medical necessity
Third, while emerging advanced diagnosis tools such as liquid biopsy and AI-based imaging platforms show tremendous promise, the practical application of these technologies in the clinic is also limited by their prospective validation, standardization, and accessibility (328)